CASPER PHARMA LLC FDA Approval NDA 010060

NDA 010060

CASPER PHARMA LLC

FDA Drug Application

Application #010060

Documents

Letter2004-06-30

Application Sponsors

NDA 010060CASPER PHARMA LLC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**1FLORINEFFLUDROCORTISONE ACETATE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1955-08-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1979-01-22STANDARD
LABELING; LabelingSUPPL10AP1982-11-18
LABELING; LabelingSUPPL12AP1988-05-09
LABELING; LabelingSUPPL13AP1993-03-31
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1994-10-11STANDARD
LABELING; LabelingSUPPL15AP1995-03-24STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1999-08-20STANDARD
LABELING; LabelingSUPPL17AP2004-06-29STANDARD

Submissions Property Types

SUPPL9Null0
SUPPL14Null0
SUPPL16Null0

CDER Filings

CASPER PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 10060
            [companyName] => CASPER PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"FLORINEF","activeIngredients":"FLUDROCORTISONE ACETATE","strength":"0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"FLORINEF","submission":"FLUDROCORTISONE ACETATE","actionType":"0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.